by In2Pharma | Dec 12, 2022 | News
The Netherlands Drug shortages are an important issue since the COVID-19 pandemic. According to the Medicines Act, each Marketing Authorisation Holder (MAH) and Wholesaler must ensure that sufficient supply of each medicine is available. The interpretation of...
by In2Pharma | Feb 27, 2018 | News
The Netherlands The Policy Rules on Inducement in the Medicines Act have been adapted and will go into effect on 1 April 2018. The main reasons for the adaptations were 1) unclarity on the limits of hourly rates for services to medical specialists, and 2) differences...